IQWiG's methods for the cost-benefit assessment. Comparison with an international reference scenario

被引:0
|
作者
Schwalm, A. [1 ]
Danner, M. [1 ]
Seidl, A. [1 ]
Volz, F. [1 ]
Dintsios, C. M. [1 ]
Gerber, A. [1 ]
机构
[1] IQWiG, D-51105 Cologne, Germany
关键词
Institute for Quality and Efficiency in Health Care; Health economic evaluation/methods; Reference case; Quality-adjusted life year (QALY); GENERAL-POPULATION; HEALTH; PREFERENCES; EFFICIENCY; DECISIONS; DRUGS; EQ-5D;
D O I
10.1007/s00103-010-1067-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Standardization of international health economic guidelines has been repeatedly requested. In this context, an international reference case was proposed, which constitutes an agreed approach for the key elements of health economic evaluation including study perspective, comparators, source of effectiveness data, role of modeling, main (economic) outcome, source of utilities, characterizing uncertainty. It is, however, questionable whether such a reference scenario can reasonably be applied across all health care systems. Our analysis pursues the question to which degree the Institute for Quality and Efficiency in Health Care's (Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, IQWiG)"General methods for evaluating the relation between cost and benefit" comply with the key elements of the reference case. In case of divergences, they will be described and discussed in light of the German social legislation and in consideration of current scientific evidence. In conclusion, the analysis revealed that IQWiG complied with the reference case in almost all aspects. Differences were found only with respect to the choice of main (economic) outcome and the source of utilities. These differences seem justified and well explained in the context of the German social legislation as well as in view of the weaknesses of the quality-adjusted life year (QALY) concept.
引用
收藏
页码:615 / 622
页数:8
相关论文
共 50 条
  • [1] Integrating Scenario Planning and Cost-Benefit Methods
    Aldrich, Stephen C.
    HASTINGS CENTER REPORT, 2018, 48 : S65 - S69
  • [2] Drug assessment. IQWiG, G-BA, and an international comparison
    Glaeske, G.
    INTERNIST, 2016, 57 (01): : 94 - 101
  • [3] Statistical agreement and cost-benefit: Comparison of methods for constructing growth reference charts
    Hermanussen, M.
    Assmann, C.
    Tutkuviene, J.
    ANNALS OF HUMAN BIOLOGY, 2010, 37 (01) : 57 - 69
  • [4] Proposed Methods of the IQWiG for Cost-Benefit-Assessment of Medical Interventions
    Koch, K.
    Dintsios, C. -M.
    Sawicki, P. T.
    GESUNDHEITSWESEN, 2009, 71 : S34 - S40
  • [5] Wo steht die Kosten-Nutzen-Bewertung des IQWiGAbgleich mit einem internationalen Referenzszenario?IQWiG’s methods for the cost–benefit assessmentComparison with an international reference scenario
    A. Schwalm
    M. Danner
    A. Seidl
    F. Volz
    C.M. Dintsios
    A. Gerber
    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2010, 53 (6) : 615 - 622
  • [6] MULTI-CRITERIA COST-BENEFIT APPROACH TO ENERGY TECHNOLOGY ASSESSMENT.
    Gottinger, Hans W.
    International Journal of Policy Analysis and Information Systems, 1981, 5 (03): : 211 - 227
  • [7] The state of the art in cost-benefit of HTS methods for stock assessment: An overview
    Rodriguez-Rodriguez, Gonzalo
    Ballesteros, Hugo M.
    Sanchez-Llamas, Eduardo
    Bande, Roberto
    Otero, Rosa Fernandez
    FRONTIERS IN MARINE SCIENCE, 2022, 9
  • [8] German Society for Health Economics e. V. Comment of dggoe on the Cost-Benefit Assessment in the IQWiG-Draft "General Methods 4.2"
    Leidl, Reiner
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2014, 19 (05): : 197 - 198
  • [9] Cost-benefit assessment of BLGCC technology
    Larson, Eric D.
    McDonald, George W.
    Yang, Wenrui
    Frederick, William James
    Iisa, Kristiina
    Kreutz, Thomas G.
    Malcolm, Earl W.
    Brown, Craig A.
    TAPPI Journal, 2000, 83 (06):
  • [10] International Experiences in Cost-Benefit Analysis - A Review
    Busse, R.
    GESUNDHEITSWESEN, 2009, 71 : S26 - S29